| Literature DB >> 12079521 |
Masaharu Tani1, Shinji Goto, Kensaku Kamada, Katsuharu Mori, Yoshishige Urata, Yoshito Ihara, Hiroshi Kijima, Yoshito Ueyama, Shobu Shibata, Takahito Kondo.
Abstract
Glioblastoma cells are highly malignant and show resistance to ionizing radiation, as well as anti-cancer drugs. This resistance to cancer therapy is often associated with a high concentration of glutathione (GSH). In this study, the effect of continuous down-regulation of gamma-glutamylcysteine synthetase (gamma-GCS) expression, a rate-limiting enzyme for GSH synthesis, on resistance to ionizing radiation and cisplatin (CDDP) was studied in T98G human glioblastoma cells. We constructed a hammerhead ribozyme against a gamma-GCS heavy subunit (gamma-GCSh) mRNA and transfected it into T98G cells. (1) The transfection of the ribozyme decreased the concentration of GSH and resulted in G1 cell cycle arrest of T98G cells. (2) The transfection of the ribozyme increased the cytotoxicity of ionizing radiation and CDDP in T98G cells. Thus, hammerhead ribozyme against gamma-GCS is suggested to have potential as a cancer gene therapy to reduce the resistance of malignant cells to ionizing radiation and anti-cancer drugs.Entities:
Mesh：
Substances：
Year: 2002 PMID： 12079521 PMCID： PMC5927042 DOI： 10.1111/j.1349-7006.2002.tb01311.x
Source DB: PubMed Journal: Jpn J Cancer Res ISSN： 0910-5050